Draupnir raises size of PolyPeptide block due to high demand
GlobalCapital, is part of the Delinian Group, DELINIAN (GLOBALCAPITAL) LIMITED, 4 Bouverie Street, London, EC4Y 8AX, Registered in England & Wales, Company number 15236213
Copyright © DELINIAN (GLOBALCAPITAL) LIMITED and its affiliated companies 2024

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement
Cookies Settings
EquityABBs-Block Trades

Draupnir raises size of PolyPeptide block due to high demand

Victoria Thiele
November 10, 2021 12:50 PM
Stunning view of the Jungfrau and mountain range of Bernese alps from Mannlichen cablecar station, Switzerland.

The majority shareholders of the Swiss pharma chemicals firm sold Sfr171 of shares at the end of the post-IPO lockup

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login

Topics

EquityMorgan StanleyCredit SuisseSwitzerland
VT
Victoria Thiele
Senior Reporter - CLOs
Contact
Gift this article